US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
JPS54113492A
(en)
|
1978-02-24 |
1979-09-05 |
Sanyo Chem Ind Ltd |
Preparation of glucoprotein derivative
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
US4970300A
(en)
|
1985-02-01 |
1990-11-13 |
New York University |
Modified factor VIII
|
US5198349A
(en)
|
1986-01-03 |
1993-03-30 |
Genetics Institute, Inc. |
Method for producing factor VIII:C and analogs
|
US5250421A
(en)
|
1986-01-03 |
1993-10-05 |
Genetics Institute, Inc. |
Method for producing factor VIII:C-type proteins
|
JPH0387173A
(ja)
|
1987-09-10 |
1991-04-11 |
Teijin Ltd |
ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体
|
US5153265A
(en)
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
US4966999A
(en)
|
1988-06-07 |
1990-10-30 |
Cytogen Corporation |
Radiohalogenated compounds for site specific labeling
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
SE466754B
(sv)
|
1990-09-13 |
1992-03-30 |
Berol Nobel Ab |
Saett att kovalent binda biopolymerer till hydrofila ytor
|
US5492821A
(en)
|
1990-11-14 |
1996-02-20 |
Cargill, Inc. |
Stabilized polyacrylic saccharide protein conjugates
|
CA2101918A1
(en)
|
1991-03-18 |
1992-09-19 |
Samuel Zalipsky |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
US5846951A
(en)
|
1991-06-06 |
1998-12-08 |
The School Of Pharmacy, University Of London |
Pharmaceutical compositions
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
AU5098193A
(en)
|
1992-09-01 |
1994-03-29 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
WO1994007510A1
(en)
|
1992-10-02 |
1994-04-14 |
Kabi Pharmacia Ab |
Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
US5298643A
(en)
|
1992-12-22 |
1994-03-29 |
Enzon, Inc. |
Aryl imidate activated polyalkylene oxides
|
AU6029594A
(en)
|
1993-01-15 |
1994-08-15 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
US5621039A
(en)
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
SE504074C2
(sv)
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
CZ287945B6
(cs)
|
1993-09-17 |
2001-03-14 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek s jeho obsahem pro léčení diabetu
|
CA2204726A1
(en)
|
1994-11-09 |
1996-12-27 |
Robin E. Offord |
Functionalized polymers for site-specific attachment
|
WO1996040662A2
(en)
|
1995-06-07 |
1996-12-19 |
Cellpro, Incorporated |
Aminooxy-containing linker compounds and their application in conjugates
|
WO1996040731A1
(en)
|
1995-06-07 |
1996-12-19 |
Mount Sinai School Of Medicine Of The City University Of New York |
Pegylated modified proteins
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
US5866538A
(en)
|
1996-06-20 |
1999-02-02 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
CA2288994C
(en)
|
1997-04-30 |
2011-07-05 |
Enzon, Inc. |
Polyalkylene oxide-modified single chain polypeptides
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
DE69841204D1
(de)
|
1997-06-04 |
2009-11-12 |
Oxford Biomedica Ltd |
Tumor gezielter Vektor
|
WO1999003496A1
(en)
|
1997-07-21 |
1999-01-28 |
The University Of North Carolina At Chapel Hill |
Factor ix antihemophilic factor with increased clotting activity
|
WO1999028455A1
(de)
|
1997-12-03 |
1999-06-10 |
Roche Diagnostics Gmbh |
Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
US6596398B1
(en)
|
1998-08-21 |
2003-07-22 |
Atofina Chemicals, Inc. |
Solar control coated glass
|
CA2351739A1
(en)
|
1998-08-28 |
2000-03-09 |
Gryphon Sciences |
Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins
|
CN1329082C
(zh)
|
1998-10-16 |
2007-08-01 |
拜奥根Idec马萨诸塞公司 |
干扰素-β-1a的聚合物缀合物及其使用
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
CA2634663C
(en)
|
1999-02-22 |
2009-08-25 |
University Of Connecticut |
Novel albumin-free factor viii formulations
|
EP1183230A1
(en)
*
|
1999-06-08 |
2002-03-06 |
La Jolla Pharmaceutical |
Valency platform molecules comprising aminooxy groups
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
CN1309423C
(zh)
|
1999-11-12 |
2007-04-11 |
马克西根控股公司 |
干扰素γ偶联物
|
US7074878B1
(en)
|
1999-12-10 |
2006-07-11 |
Harris J Milton |
Hydrolytically degradable polymers and hydrogels made therefrom
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
WO2001058935A2
(en)
|
2000-02-11 |
2001-08-16 |
Maxygen Aps |
FACTOR VII OR VIIa-LIKE MOLECULES
|
EP1280548B1
(en)
|
2000-05-03 |
2013-12-11 |
Novo Nordisk Health Care AG |
Subcutaneous administration of coagulation factor VII
|
JP4455802B2
(ja)
|
2000-05-03 |
2010-04-21 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
ヒト第vii凝固因子変異型
|
JP2003535208A
(ja)
|
2000-06-08 |
2003-11-25 |
ラ ホヤ ファーマシューティカル カンパニー |
高分子量ポリエチレン・オキシドを含む多価プラットホーム分子
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
AU8755001A
(en)
|
2000-09-13 |
2002-03-26 |
Novo Nordisk As |
Human coagulation factor vii variants
|
HUP0301245A3
(en)
|
2000-10-02 |
2005-12-28 |
Novo Nordisk Healthcare Ag |
Tmethod for the production of vitamin k-dependent proteins
|
GB0103877D0
(en)
*
|
2001-02-16 |
2001-04-04 |
King S College London |
Novel Drug Delivery system
|
RU2338752C2
(ru)
|
2001-03-22 |
2008-11-20 |
Ново Нордиск Хелт Кэр Аг |
Производные фактора vii свертывания крови
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
DK1578771T3
(da)
|
2001-10-10 |
2013-06-10 |
Novo Nordisk As |
Remodellering og glycokonjugering af peptider
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
AU2002352524B2
(en)
|
2001-11-07 |
2007-10-04 |
Nektar Therapeutics |
Branched polymers and their conjugates
|
AU2002351197A1
(en)
|
2001-11-28 |
2003-06-10 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
WO2003046150A2
(en)
|
2001-11-28 |
2003-06-05 |
Neose Technologies, Inc. |
Glycoprotein remodeling using endoglycanases
|
ES2363205T3
(es)
|
2002-06-21 |
2011-07-26 |
Novo Nordisk Health Care Ag |
Glicoformas del factor vii pegilado.
|
US7087229B2
(en)
|
2003-05-30 |
2006-08-08 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
US7122189B2
(en)
|
2002-08-13 |
2006-10-17 |
Enzon, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
DE02020425T1
(de)
|
2002-09-11 |
2004-07-15 |
Fresenius Kabi Deutschland Gmbh |
Hasylierte Polypeptide, besonders hasyliertes Erythropoietin
|
EP1681303B1
(en)
|
2002-09-11 |
2013-09-04 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
PL217085B1
(pl)
|
2002-09-11 |
2014-06-30 |
Fresenius Kabi Gmbh |
Koniugat hydroksyalkiloskrobi i polipeptydu, sposób wytwarzania koniugatu hydroksyalkiloskrobi i polipeptydu, zastosowanie koniugatu hydroksyalkiloskrobi i polipeptydu oraz kompozycja farmaceutyczna koniugatu hydroksyalkiloskrobi i polipeptydu
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
ATE399185T1
(de)
|
2002-12-31 |
2008-07-15 |
Nektar Therapeutics Al Corp |
Maleinsäureamid polymerderivate und ihre biokonjugate
|
AU2003300133B2
(en)
|
2002-12-31 |
2008-11-13 |
Nektar Therapeutics |
Hydrolytically stable maleimide-terminated polymers
|
DK1596887T3
(da)
|
2003-02-26 |
2022-06-20 |
Nektar Therapeutics |
Polymer-Faktor VIII-konjugat
|
US7623892B2
(en)
|
2003-04-02 |
2009-11-24 |
Palm, Inc. |
System and method for enabling a person to switch use of computing devices
|
PT1620118E
(pt)
|
2003-04-08 |
2014-10-16 |
Yeda Res & Dev |
Fármacos peguilados de modo reversível
|
SG155777A1
(en)
|
2003-04-09 |
2009-10-29 |
Neose Technologies Inc |
Glycopegylation methods and proteins/peptides produced by the methods
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
TWI356065B
(en)
*
|
2003-08-08 |
2012-01-11 |
Fresenius Kabi De Gmbh |
Method of producing hydroxyalkyl starch derivative
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
JP2007501811A
(ja)
|
2003-08-08 |
2007-02-01 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
治療的な関心対象のタンパク質に対する遅延分子の選択的な化学物質接合のためのガラクトースオキシダーゼの使用。
|
US20080206182A1
(en)
|
2003-08-08 |
2008-08-28 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of a Polymer and a Protein Linked by an Oxime Group
|
WO2005016949A2
(en)
|
2003-08-12 |
2005-02-24 |
Lipoxen Technologies Limited |
Sialic acid derivatives
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
ES2422187T3
(es)
|
2003-12-03 |
2013-09-09 |
Biogenerix Ag |
Factor estimulante de colonias de granulocitos glicopegilados
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
JP4738346B2
(ja)
|
2003-12-03 |
2011-08-03 |
ノヴォ ノルディスク アー/エス |
GlycoPEG化された第IX因子
|
EP1765853B1
(en)
|
2004-01-08 |
2015-10-28 |
ratiopharm GmbH |
O-linked glycosylation of G-CSF peptides
|
WO2005092369A2
(en)
|
2004-03-11 |
2005-10-06 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyethyl starch and erythropoietin
|
GB0412181D0
(en)
*
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
WO2006020372A2
(en)
|
2004-07-23 |
2006-02-23 |
Neose Technologies, Inc. |
Enzymatic modification of glycopeptides
|
WO2006013202A2
(en)
|
2004-08-02 |
2006-02-09 |
Novo Nordisk Health Care Ag |
Conjugation of fvii
|
EP1776389B1
(en)
|
2004-08-12 |
2016-06-29 |
Lipoxen Technologies Limited |
Sialic acid derivatives
|
WO2006031811A2
(en)
|
2004-09-10 |
2006-03-23 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
KR20180110192A
(ko)
|
2004-11-12 |
2018-10-08 |
바이엘 헬스케어 엘엘씨 |
Fviii의 부위 지향 변형
|
DK2399893T3
(en)
|
2004-12-22 |
2018-10-08 |
Ambrx Inc |
COMPOSITIONS CONTAINING, INVOLVING PROCEDURES, AND USES OF NON-NATURAL AMINO ACIDS AND POLYPEPTIDES
|
KR20070092754A
(ko)
|
2004-12-27 |
2007-09-13 |
백스터 인터내셔널 인코포레이티드 |
중합체 - 폰 빌레브란트 인자 - 접합체
|
EP1838332A1
(en)
|
2005-01-06 |
2007-10-03 |
Neose Technologies, Inc. |
Glycoconjugation using saccharyl fragments
|
KR20080013850A
(ko)
*
|
2005-02-08 |
2008-02-13 |
더 카운실 오브 더 퀸즐랜드 인스티튜트 오브 메디컬 리서치 |
면역원성 분자
|
BRPI0611872B8
(pt)
|
2005-06-16 |
2021-05-25 |
Nektar Therapeutics |
reagente polimérico, conjugado, método para preparação de um conjugado e composição farmacêutica
|
JP5335422B2
(ja)
|
2005-06-17 |
2013-11-06 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
少なくとも1つの非天然のシステインを含んでいる操作されたタンパク質の選択的な還元および誘導体化
|
US20090017007A1
(en)
|
2005-08-26 |
2009-01-15 |
Maxygen Holdings Ltd. |
Liquid factor vii composition
|
AU2006286486A1
(en)
*
|
2005-08-30 |
2007-03-08 |
Novo Nordisk Health Care Ag |
Liquid formulations of pegylated growth hormone
|
AU2006330858A1
(en)
|
2005-12-21 |
2007-07-05 |
Wyeth |
Protein formulations with reduced viscosity and uses thereof
|
US20090093405A1
(en)
*
|
2006-01-19 |
2009-04-09 |
Ambrx, Inc. |
Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
NZ572050A
(en)
|
2006-03-31 |
2011-09-30 |
Baxter Int |
Factor VIII conjugated to polyethylene glycol
|
US20090285780A1
(en)
|
2006-05-24 |
2009-11-19 |
Chyi Lee |
Peg linker compounds and biologically active conjugates thereof
|
US7939632B2
(en)
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
ES2565180T3
(es)
|
2006-07-13 |
2016-04-01 |
Serum Institute Of India Ltd, |
Proceso para la preparación de ácido polisiálico de gran pureza
|
JP5570809B2
(ja)
*
|
2006-09-01 |
2014-08-13 |
ノボ ノルディスク ヘルス ケア アーゲー |
修飾タンパク質
|
US8969532B2
(en)
|
2006-10-03 |
2015-03-03 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
|
CN101588820A
(zh)
*
|
2006-11-17 |
2009-11-25 |
尼亚哈姆雷特药品公司 |
α-乳清蛋白组合物
|
EP2101821B1
(en)
|
2006-12-15 |
2014-08-13 |
Baxter International Inc. |
Factor viia- (poly) sialic acid conjugate having prolonged in vivo half-life
|
WO2008083346A1
(en)
|
2006-12-28 |
2008-07-10 |
Ambrx, Inc. |
Phenazine and quinoxaline substituted amino acids and polypeptides
|
JP5558106B2
(ja)
|
2007-01-03 |
2014-07-23 |
ノボ ノルディスク ヘルス ケア アーゲー |
凝固第vii因子関連ポリペプチドの皮下投与
|
WO2008119815A1
(en)
|
2007-04-02 |
2008-10-09 |
Novo Nordisk A/S |
Subcutaneous administration of coagulation factor ix
|
US7700551B2
(en)
|
2007-06-26 |
2010-04-20 |
Baxter International Inc. |
Hydrolysable polymeric FMOC-linker
|
AU2008272792B2
(en)
|
2007-07-03 |
2014-03-06 |
Children's Hospital & Research Center At Oakland |
Oligosialic acid derivatives, methods of manufacture, and immunological uses
|
BRPI0818288A2
(pt)
|
2007-10-09 |
2015-04-14 |
Polytherics Ltd |
Proteínas conjugadas e peptídeos.
|
EP2070951A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Method for producing a hydroxyalkyl starch derivatives with two linkers
|
CN102037004A
(zh)
|
2008-01-08 |
2011-04-27 |
生物种属学股份公司 |
使用寡糖基转移酶的多肽的糖缀合
|
KR101582841B1
(ko)
|
2008-02-27 |
2016-01-11 |
노보 노르디스크 에이/에스 |
콘쥬게이트된 인자 viii 분자
|
KR20110016440A
(ko)
|
2008-04-24 |
2011-02-17 |
셀틱 파르마 피이지 엘티디. |
연장된 반감기를 가진 제 ⅰⅹ 인자 접합체
|
CN102065899A
(zh)
|
2008-05-23 |
2011-05-18 |
诺沃-诺迪斯克保健股份有限公司 |
含有高浓度的芳香族防腐剂的peg-官能化的丝氨酸蛋白酶的制剂
|
JP5642065B2
(ja)
|
2008-05-23 |
2014-12-17 |
ノボ ノルディスク ヘルス ケア アーゲー |
ペグ化されたgla−ドメイン含有タンパク質を含む低粘度組成物
|
AU2009256093A1
(en)
|
2008-06-04 |
2009-12-10 |
Bayer Healthcare Llc |
FVIII muteins for treatment of von Willebrand disease
|
DK2374481T3
(en)
|
2008-07-21 |
2016-02-01 |
Polytherics Ltd |
New reagents and methods for the conjugation of biological molecules
|
KR20110093775A
(ko)
|
2008-11-03 |
2011-08-18 |
바이엘 헬스케어 엘엘씨 |
혈우병 치료 방법
|
US20120121613A1
(en)
|
2009-01-19 |
2012-05-17 |
Bayer Healthcare Llc |
Protein conjugate having an endopeptidase- cleavable bioprotective moiety
|
WO2010102886A1
(en)
|
2009-02-19 |
2010-09-16 |
Novo Nordisk A/S |
Modification of factor viii
|
US9005598B2
(en)
|
2009-03-04 |
2015-04-14 |
Polytherics Limited |
Conjugated proteins and peptides
|
WO2010120365A2
(en)
|
2009-04-16 |
2010-10-21 |
Wu Nian |
Protein-carrier conjugates
|
US20120134977A1
(en)
|
2009-06-01 |
2012-05-31 |
Yeda Research And Development Co. Ltd. |
Prodrugs containing albumin binding probe
|
EA201290069A1
(ru)
|
2009-07-31 |
2012-07-30 |
Байер Хелскер Ллс |
Модифицированные полипептиды фактора ix и их применения
|
DE102009028526A1
(de)
|
2009-08-13 |
2011-02-24 |
Leibniz-Institut Für Polymerforschung Dresden E.V. |
Verfahren zur Modifikation und Funktionalisierung von Sacchariden
|
US20120178914A1
(en)
|
2009-09-25 |
2012-07-12 |
Vybion, Inc. |
Polypeptide modification
|
JP5827955B2
(ja)
|
2009-11-24 |
2015-12-02 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
Peg化タンパク質の精製方法
|
EP2536752B1
(en)
*
|
2010-02-16 |
2015-04-08 |
Novo Nordisk A/S |
Modified recombinant Factor VIII
|
US20130040888A1
(en)
|
2010-02-16 |
2013-02-14 |
Novo Nordisk A/S |
Factor VIII Molecules With Reduced VWF Binding
|
GB201007357D0
(en)
|
2010-04-30 |
2010-06-16 |
Leverton Licence Holdings Ltd |
Conjugated factor VIII
|
GB201007356D0
(en)
|
2010-04-30 |
2010-06-16 |
Leverton Licence Holdings Ltd |
Conjugated factor VIIa
|
SG187171A1
(en)
|
2010-07-30 |
2013-02-28 |
Baxter Int |
Nucleophilic catalysts for oxime linkage
|
WO2012068134A1
(en)
|
2010-11-15 |
2012-05-24 |
Biogen Idec Inc. |
Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
|
EP3513804B1
(en)
|
2011-07-08 |
2022-03-23 |
Bioverativ Therapeutics Inc. |
Factor viii chimeric and hybrid polypeptides, and methods of use thereof
|